Accelerating the discovery of vaccines and antiviral therapies against SARS-CoV-2, influenza, dengue, Zika, and other viruses

Critical virology reagents

20+ years virology expertise

Trusted by 100+ labs

RVP Technology    |    RVP Catalog    |      RVP Applications     |   Case Studies   |   Publications  |   FAQs

Reporter Virus Particles: Pseudoviruses for Safe Neutralization Data

Reporter Virus Particles (RVPs) are replication-incompetent pseudovirus particles that enable safe (BSL-2), easy, and high-throughput viral infectivity and neutralization assays using standard detection instrumentation.
Reporter Virus Particles: Pseudoviruses for Safe Neutralization Data
  • Safe in a BSL-2 environment
  • Quantitative (luciferase) or fluorescent (GFP) read-out
  • Quality-controlled critical reagents based on 20+ years of virology expertise and experience manufacturing reporter viruses

“SARS-CoV-2 RVPs really helped us a lot since we did not have much previous expertise in SARS. The user meetings were especially helpful.”


RVPs: The Most Extensive Catalog of Reporter Virus Particles

Catalog of Reporter Virus Particles

Accelerating Clinical Development: RVPs for Vaccines and Antibodies

The Integral Advantage: 20+Years of Virology Experience ​

Deep expertise in virology is at the core of Integral Molecular’s 20-year history, and we have co-authored over 70 peer-reviewed virology publications in journals including Cell, Science and Nature. With the support of NIAID, scientists at Integral Molecular have been on the forefront of combatting viral epidemics including COVID-19, Zika, Ebola, and Chikungunya. Meet our team.

Trusted by 100+ Laboratories for R&D and Clinical Trials ​

reporter virus particles

Publications Establishing RVPs as a Critical Reagent

Frequently Asked Questions

Ready To Get Started?

We have worked with more than 100 top biotech and pharmaceutical companies to help them succeed. Let’s talk about how we can help you.

Or call (215) 966-6061